Document is current

Article History

Received: 11 February 2025

Accepted: 25 March 2025

First Online: 12 April 2025

Declarations

:

: Outside the submitted work, Matteo Bassetti has received funding for scientific advisory boards, travel, and speaker honoraria from Cidara, Gilead, Menarini, MSD, Mundipharma, Pfizer, Shionogi. Matteo Bassetti is an Editorial Board Member of Infectious Diseases and Therapy. Matteo Bassetti was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Outside the submitted work, Daniele Roberto Giacobbe reports investigator-initiated grants from Pfizer, Shionogi, bioMérieux, Menarini, Tillotts Pharma, and Gilead Italia, travel support from Pfizer, and speaker/advisor fees from Pfizer, Menarini, bioMérieux, Advanz Pharma, and Tillotts Pharma. Outside the submitted work, Antonio Vena has received funding for scientific advisory boards, travel, and speaker honoraria from Pfizer, Shionogi, Menarini, Tillotts Pharma, and Gilead Italia, Advanz Pharma, and Tillotts Pharma. Outside the present work, Garyphallia Poulakou reports consultancy fees/Honoraria Menarini, Gilead, SOBI, AstraZeneca, MSD, GSK, Pfizer. Outside the present work, Gian Maria Rossolini reports grants from Ada, Alifax, Cepheid, Diesse Diagnostica Senese, Gradientech, Menarini, Qlinea, Quantamatrix, Quidel, Qvella, Relab, SD Biosensor, Seegene, and Shionogi, scientific consultancies with Advanz Pharma, bioMérieux, Menarini, MSD, Panakes, Pfizer, Shionogi, and Viatris, and speakers bureau from bioMérieux, Menarini, MSD, Pfizer, and Shionogi. Outside the present work, Alex Soriano reports consultant fees/honoraria for lectures or advisory boards from Pfizer, Menarini, Shionogi, Advance Pharma, Angelini, and Gilead. Alex Soriano is an Editor-in-Chief of Infectious Diseases and Therapy. Alex Soriano was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. David P Nicolau is a consultant, speaker bureau member or has received research funding from Abbvie, CARB-X, Cepheid, Innoviva, Merck, Pfizer, Shionogi, and Wockhardt.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.